Image 1
Orphenadrine Citrate Injection
Product Images NDC 0591-3222
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 0591-3222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Orphenadrine Citrate Injection is a prescription medication that is administered through injection for Intravenous or Intramuscular Use. It is available in Sterile Ampules containing 30mg/mL of the medication. Each 2mL ampule contains different ingredients, including S0 Sodum, Metbiie 091, Sadum CHonde 25, e for et 45, Sodum i ondlo, Hydochiont Aoy, and Grpnensarn Cste. The dosage and price information is not available. The medication is manufactured by Actavis and is only available upon a doctor's prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
